Viewing StudyNCT01520389



Ignite Creation Date: 2024-05-06 @ 12:13 AM
Last Modification Date: 2024-10-26 @ 10:46 AM
Study NCT ID: NCT01520389
Status: COMPLETED
Last Update Posted: 2018-03-21
First Post: 2012-01-13

Brief Title: Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Sponsor: Merrimack Pharmaceuticals
Organization: Merrimack Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Triple Negative Breast Cancer
Advanced Solid Tumors
Colorectal Cancer
Squamous Cell Head and Neck Cancer
Non Small Cell Lung Cancer
Keywords:
Name View
irinotecan View
cancer View
solid tumors View
oncology View
Phase I View
EGFR View
EGF receptor ErbB1 View